BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 18086011)

  • 41. Heterologous Boost Following
    Wu Y; Cai M; Ma J; Teng X; Tian M; Bassuoney EBMB; Fan X
    Front Immunol; 2018; 9():2439. PubMed ID: 30425711
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PD-1-PD-L1 pathway impairs T(h)1 immune response in the late stage of infection with Mycobacterium bovis bacillus Calmette-Guérin.
    Sakai S; Kawamura I; Okazaki T; Tsuchiya K; Uchiyama R; Mitsuyama M
    Int Immunol; 2010 Dec; 22(12):915-25. PubMed ID: 21047981
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of immunisation with Mycobacterium bovis bacillus Calmette-Guérin on the sensitisation to inhaled allergens after infection with respiratory syncytial virus.
    Vonberg RP; Mueller M; Emmendoerffer A; Freihorst J
    Clin Exp Med; 2005 Dec; 5(4):177-83. PubMed ID: 16362797
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MyD88-dependent activation of dendritic cells and CD4(+) T lymphocytes mediates symptoms, but is not required for the immunological control of parasites during rodent malaria.
    Franklin BS; Rodrigues SO; Antonelli LR; Oliveira RV; Goncalves AM; Sales-Junior PA; Valente EP; Alvarez-Leite JI; Ropert C; Golenbock DT; Gazzinelli RT
    Microbes Infect; 2007 Jun; 9(7):881-90. PubMed ID: 17537666
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gammadelta T cells but not NK cells are essential for cell-mediated immunity against Plasmodium chabaudi malaria.
    Weidanz WP; LaFleur G; Brown A; Burns JM; Gramaglia I; van der Heyde HC
    Infect Immun; 2010 Oct; 78(10):4331-40. PubMed ID: 20660608
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasmodium chabaudi chabaudi infection in mice induces strong B cell responses and striking but temporary changes in splenic cell distribution.
    Achtman AH; Khan M; MacLennan IC; Langhorne J
    J Immunol; 2003 Jul; 171(1):317-24. PubMed ID: 12817013
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CD4+ T cells mediate IFN-gamma-independent control of Mycobacterium tuberculosis infection both in vitro and in vivo.
    Cowley SC; Elkins KL
    J Immunol; 2003 Nov; 171(9):4689-99. PubMed ID: 14568944
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Production of interleukin 10 during malaria caused by lethal and nonlethal variants of Plasmodium yoelii yoelii.
    Kobayashi F; Morii T; Matsui T; Fujino T; Watanabe Y; Weidanz WP; Tsuji M
    Parasitol Res; 1996; 82(5):385-91. PubMed ID: 8738275
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection.
    Xu ZZ; Chen X; Hu T; Meng C; Wang XB; Rao Y; Zhang XM; Yin YL; Pan ZM; Jiao XA
    Front Cell Infect Microbiol; 2016; 6():3. PubMed ID: 26858942
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD8+ T lymphocyte-mediated loss of marginal metallophilic macrophages following infection with Plasmodium chabaudi chabaudi AS.
    Beattie L; Engwerda CR; Wykes M; Good MF
    J Immunol; 2006 Aug; 177(4):2518-26. PubMed ID: 16888013
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Induction of cytotoxic T-cell responses against culture filtrate antigens in Mycobacterium bovis bacillus Calmette-Guérin-infected mice.
    Denis O; Lozes E; Huygen K
    Infect Immun; 1997 Feb; 65(2):676-84. PubMed ID: 9009330
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.
    Lu M; Xia ZY; Bao L
    Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Listeria monocytogenes inoculation protects mice against blood-stage Plasmodium yoelii infection.
    Qi Z; Han X; Zhang Y; Wang J; Cao YM
    Tohoku J Exp Med; 2013 Feb; 229(2):87-96. PubMed ID: 23303295
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Murine Splenic Natural Killer Cells Do Not Develop Immunological Memory after Re-Encounter with Mycobacterium bovis BCG.
    Kawahara M; Hasegawa N; Takaku H
    PLoS One; 2016; 11(3):e0152051. PubMed ID: 26999357
    [TBL] [Abstract][Full Text] [Related]  

  • 55. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
    Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM
    J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mycobacterium bovis BCG Vaccination Induces Divergent Proinflammatory or Regulatory T Cell Responses in Adults.
    Boer MC; Prins C; van Meijgaarden KE; van Dissel JT; Ottenhoff TH; Joosten SA
    Clin Vaccine Immunol; 2015 Jul; 22(7):778-88. PubMed ID: 25947145
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Suppression of in vitro IFN-gamma production by spleen cells of Plasmodium chabaudi-infected C57BL/10 mice exposed to dexamethasone at a low dose.
    Tsutsui N; Kamiyama T
    Int J Immunopharmacol; 1998; 20(4-5):141-52. PubMed ID: 9730250
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protective CD4+ T-cell lines raised against Plasmodium chabaudi show characteristics of either Th1 or Th2 cells.
    Taylor-Robinson AW; Phillips RS
    Parasite Immunol; 1993 Jun; 15(6):301-10. PubMed ID: 8103212
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fluctuations of Spleen Cytokine and Blood Lactate, Importance of Cellular Immunity in Host Defense Against Blood Stage Malaria
    Imai T; Suzue K; Ngo-Thanh H; Ono S; Orita W; Suzuki H; Shimokawa C; Olia A; Obi S; Taniguchi T; Ishida H; Van Kaer L; Murata S; Tanaka K; Hisaeda H
    Front Immunol; 2019; 10():2207. PubMed ID: 31608052
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG-mediated protection in a murine model of tuberculosis.
    Zelmer A; Tanner R; Stylianou E; Damelang T; Morris S; Izzo A; Williams A; Sharpe S; Pepponi I; Walker B; Hokey DA; McShane H; Brennan M; Fletcher H
    BMC Infect Dis; 2016 Aug; 16():412. PubMed ID: 27519524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.